Skip to main content

RT @doctorRBC: New biomarkers of increased disease activity in PsA? Tissue remodeling and inflammation (neutrophil activ

Social Author Name
Robert B Chao, MD
Tweet Content
New biomarkers of increased disease activity in PsA? Tissue remodeling and inflammation (neutrophil activity and fibrosis) biomarkers showed best performance in differentiating PsA w/ flares and without. Abs#1610 @RheumNow #ACR22 https://t.co/73ta7VXgTY

RT @RichardPAConway: Kiltz et al. Greater efficacy of secukinumab in normal BMI than high BMI AS patients. Decremental e

Social Author Name
Richard Conway
Tweet Content
Kiltz et al. Greater efficacy of secukinumab in normal BMI than high BMI AS patients. Decremental effect with increasing BMI. @RheumNow #ACR22 Abstr#1495 https://t.co/zwEmQsJmPT https://t.co/nOW2IbTc5t

RT @RichardPAConway: Dörner et al. Remibrutinib (BTKi) in pSS. + study in pSS! Improved ESSDAI (disease activity), no e

Social Author Name
Richard Conway
Tweet Content
Dörner et al. Remibrutinib (BTKi) in pSS. + study in pSS! Improved ESSDAI (disease activity), no effect ESSPRI (PRO), trend to improve salivary flow, + effect on multiple labs. @RheumNow #ACR22 Abstr#1113 https://t.co/m2rvXbqq7b https://t.co/jQLyP66zX9

RT @RichardPAConway: Benesova et al. Higher treatment response to secukinumab in both male and female AS patients when d

Social Author Name
Richard Conway
Tweet Content
Benesova et al. Higher treatment response to secukinumab in both male and female AS patients when diagnosed earlier. No such effect seen in PsA patients. Emphasises need to reduce diagnostic delay in AS. @RheumNow #ACR22 Abstr#1497 https://t.co/9g2zN85a33 https://t.co/LfvQFTKr69

RT @AurelieRheumo: Promising results for Izokibep in PsA Ph2 RCT meets primary endpoint at Wk 16 ACR50: 13% PBO 48%

Social Author Name
Aurelie Najm
Tweet Content
Promising results for Izokibep in PsA Ph2 RCT meets primary endpoint at Wk 16 ACR50: 13% PBO 48% 40mg IZO 52% 80mg IZO MDA: 5% PBO 42% 40mg 39% 80mg Results observed as soon as wk2 No new safety signal compared to IL17Ai https://t.co/Gilhg5k36b Abs#1597 #ACR22 @RheumNow https://t.co/VvxSRLtkFk

RT @uptoTate: Abs 1187 apremilast may have beneficial effects on cardiometabolic measures including reductions in HbA1c

Social Author Name
Dr. Rachel Tate
Tweet Content
Abs 1187 apremilast may have beneficial effects on cardiometabolic measures including reductions in HbA1c in severely obese patients and reductions in weight and dz activity improvements in PsO/ PsA outcomes across all BMI categories. #ACR22 @RheumNow https://t.co/fCdJxz2IDk https://t.co/mLnwKQs539

RT @uptoTate: Enjoy the post-session adult beverage #ACR22 and #rheumtwitter but, choose wisely as Abs 1206 finds beer c

Social Author Name
Dr. Rachel Tate
Tweet Content
Enjoy the post-session adult beverage #ACR22 and #rheumtwitter but, choose wisely as Abs 1206 finds beer consumption was consistently assoc'd w/ higher serum urate levels, whereas sake showed only modest associations in both males and females. @RheumNow https://t.co/ETtU31iTZ0 https://t.co/keG5IN7LbC

RT @uptoTate: Dr. @Drbeckyg reminds us that self-reported, RA patient completed joint counts are good for tender and ok

Social Author Name
Dr. Rachel Tate
Tweet Content
Dr. @Drbeckyg reminds us that self-reported, RA patient completed joint counts are good for tender and ok for swollen. Check out her videos for teaching joint counts to your patients - all under 8 minutes in total. #ACR22 @RheumNow https://t.co/E2wBsNFS12
Subscribe to
×